37 results
8-K
NMRA
Neumora Therapeutics Inc.
14 Jun 24
Submission of Matters to a Vote of Security Holders
4:01pm
of the selection by the audit committee of the board of directors of the Company of Ernst & Young LLP as the independent registered public accounting firm
DEFA14A
jrsj7sk939m8
25 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
z9ric0zb1s5
25 Apr 24
Definitive proxy
4:05pm
10-K
EX-31.1
pg80f0nhn5b ufljgr
7 Mar 24
Annual report
4:05pm
10-K
qkeogp8zeytlk ph
7 Mar 24
Annual report
4:05pm
10-K
EX-31.2
tyuz5wg5vvebzn5pv
7 Mar 24
Annual report
4:05pm
10-Q
EX-31.1
yxm 1hm3d
1 Nov 23
Quarterly report
4:05pm
10-Q
jvisb
1 Nov 23
Quarterly report
4:05pm
10-Q
EX-31.2
c2n 5cuw1g
1 Nov 23
Quarterly report
4:05pm
424B4
gfb1h6zabpq
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
EX-1.1
dsjlyc qc9l
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
h93b7wts
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-10.21
0qhaifjnil4fsjxi
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.12
dg0ot2 9p
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.14
3hpo4rgdpdmo
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
6q9 vmk73o
25 Aug 23
IPO registration
5:03pm